色谱法
化学
甲酸铵
蛋白质沉淀
生物等效性
检出限
选择性反应监测
分析物
人血浆
电喷雾电离
生物分析
高效液相色谱法
质谱法
分析化学(期刊)
串联质谱法
药代动力学
医学
内科学
作者
Mamdouh R. Rezk,Kamal A. Badr,Naglaa S. Abdel‐Naby,Magy M. Ayyad
摘要
Abstract A novel, simple and rapid UPLC–MS/MS method was developed and validated for determination of favipiravir (FAV) in human plasma. Lamivudine was used as an internal standard (IS). The Xevo TQD LC–MS/MS was operated under the multiple‐reaction monitoring mode using electrospray ionization. Precipitation with acetonitrile was used in sample preparation as it gives relatively cleaner plasma samples. The prepared samples were chromatographed using an Acquity UPLC® HSS C18 (100 × 2.1 mm, 1.8 μm) column. The mobile phase was composed of ammonium formate and methanol in a gradient mode that was pumped at a flow rate of 0.35 ml/min. The developed method was validated as per the FDA guidelines and linearity was in the range of 0.25–16 μg/ml for FAV. The intra‐ and inter‐day precision and accuracy results were within the acceptable limits. A run time of 4.5 min and a low quantification limit of FAV allowed the application of the developed method for the determination of FAV in a bioequivalence study in healthy human volunteers.
科研通智能强力驱动
Strongly Powered by AbleSci AI